BayStreetGuruInvesting in Biotech: Why 2024 Could Be the Year of Major Gains2024 sees a biotech rebound, with over 15 IPOs by mid-year and capital inflows increasing across the sector.17h ago17h ago
BayStreetGuru🧵 Pair Trade Idea: Bright Minds $DRUG vs. Longboard Pharmaceuticals $LBPH 🧵Overview18h ago18h ago
BayStreetGuruBright Minds Biosciences to Host Investor & Analyst KOL Event on September 25thBright Minds Biosciences has announced the commencement of its Phase 2 clinical trial for BMB-101.19h ago19h ago
BayStreetGuruThe Race for U.S. Lithium Independence in the EV Revolution $LIFTLithium demand is projected to quadruple by 2030, driven by the electric vehicle boom and increasing global energy storage needs.20h ago20h ago
BayStreetGuruThe Future of Cancer Therapy is Here (NASDAQ: RNXT)RenovoRx’s TAMP™ technology delivers chemotherapy directly to tumors, reducing side effects and improving treatment efficacy.2d ago2d ago
BayStreetGuruAdvancing Neurological Solutions with Game-Changing ScienceBright Minds Biosciences Inc. (NASDAQ: DRUG) is a biotechnology company focused on developing novel therapies for neurological and…6d ago6d ago
BayStreetGuruLi-FT Power Expands Horizons in Canada’s Lithium Market (TSXV: LIFT, OTC: LIFFF, FRA: WS0)Li-FT Power continues to grow its portfolio, recently acquiring 9,681 hectares at the Cali Project and the Shorty West Lithium claim to…Sep 17Sep 17
BayStreetGuruLi-FT Power: Fueling the EV Future with Strategic Lithium ExplorationLi-FT Power Ltd. (“LIFT” or the “Company”) (CSE: LIFT) (OTCQX: LIFFF) (Frankfurt: WS0) is a mineral exploration company engaged in the…Sep 16Sep 16
BayStreetGuruAmerica’s Fight for Uranium Freedom: Will It Ever End?The U.S. is actively working to reduce its reliance on foreign uranium, particularly from Russia, through domestic mining and strategic…Sep 16Sep 16
BayStreetGuruBright Minds Targets Epilepsy with Breakthrough 5-HT2C Agonist (CSE:DRUG)Bright Minds Biosciences launches a Phase 2 trial for BMB-101, targeting drug-resistant epilepsy with high unmet needs.Sep 16Sep 16